Junzhe Chen

1.1k total citations
49 papers, 754 citations indexed

About

Junzhe Chen is a scholar working on Nephrology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Junzhe Chen has authored 49 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Nephrology, 10 papers in Infectious Diseases and 10 papers in Molecular Biology. Recurrent topics in Junzhe Chen's work include Acute Kidney Injury Research (9 papers), COVID-19 Clinical Research Studies (8 papers) and Chronic Kidney Disease and Diabetes (5 papers). Junzhe Chen is often cited by papers focused on Acute Kidney Injury Research (9 papers), COVID-19 Clinical Research Studies (8 papers) and Chronic Kidney Disease and Diabetes (5 papers). Junzhe Chen collaborates with scholars based in China, Hong Kong and United States. Junzhe Chen's co-authors include Hui Y. Lan, Ying Tang, Anping Xu, Wenbiao Wang, Xueqing Yu, Mingsheng Zhu, Xiao‐Ru Huang, Qiuyan Huang, Sha Fu and Xiao Ru Huang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Advanced Science.

In The Last Decade

Junzhe Chen

41 papers receiving 745 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junzhe Chen China 18 191 182 151 145 127 49 754
Jianyong Zhong United States 16 349 1.8× 237 1.3× 80 0.5× 79 0.5× 72 0.6× 41 743
Carine M. Boustany‐Kari United States 17 416 2.2× 407 2.2× 251 1.7× 152 1.0× 108 0.9× 20 1.3k
Tomás P. Griffin Ireland 17 134 0.7× 168 0.9× 81 0.5× 32 0.2× 99 0.8× 52 853
Vanessa Marchant Spain 12 176 0.9× 244 1.3× 41 0.3× 82 0.6× 119 0.9× 25 658
Thomas J. Raife United States 23 140 0.7× 308 1.7× 64 0.4× 45 0.3× 331 2.6× 67 1.5k
Zeyuan Lu China 15 246 1.3× 249 1.4× 77 0.5× 41 0.3× 69 0.5× 29 715
Sotiria G. Giotaki Greece 11 48 0.3× 187 1.0× 200 1.3× 63 0.4× 87 0.7× 29 479
Kemal Erbil Türkiye 12 128 0.7× 123 0.7× 187 1.2× 53 0.4× 47 0.4× 19 638
Bi Cheng Liu China 16 243 1.3× 386 2.1× 85 0.6× 31 0.2× 130 1.0× 29 871

Countries citing papers authored by Junzhe Chen

Since Specialization
Citations

This map shows the geographic impact of Junzhe Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junzhe Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junzhe Chen more than expected).

Fields of papers citing papers by Junzhe Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junzhe Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junzhe Chen. The network helps show where Junzhe Chen may publish in the future.

Co-authorship network of co-authors of Junzhe Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Junzhe Chen. A scholar is included among the top collaborators of Junzhe Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junzhe Chen. Junzhe Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chen, Junzhe, et al.. (2025). Outcomes after liposuction-based treatment of lymphedema: a systematic review and meta-analysis. Frontiers in Oncology. 15. 1651472–1651472.
3.
Liu, Yang, Wenbiao Wang, Wenjing Wu, et al.. (2025). SARS-CoV-2 N protein induces hypokalemia in acute kidney injury mice via ENaC-dependent mechanism. Molecular Therapy. 33(8). 3778–3788.
4.
Chen, Junzhe, et al.. (2025). Case Report: Surgical management of primary lymphedema with a novel PROX1 mutation involving upper and lower limbs. Frontiers in Genetics. 16. 1560471–1560471. 1 indexed citations
5.
Chen, Junzhe, et al.. (2025). Gut microbiota as a mediator of cancer development and management: From colitis to colitis-associated dysplasia and carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1880(4). 189381–189381. 2 indexed citations
6.
Zhong, Yu, Biao Wei, Wenbiao Wang, et al.. (2024). Single-Cell RNA-Sequencing Identifies Bone Marrow-Derived Progenitor Cells as a Main Source of Extracellular Matrix-Producing Cells Across Multiple Organ-Based Fibrotic Diseases. International Journal of Biological Sciences. 20(13). 5027–5042. 7 indexed citations
7.
Chen, Junzhe, et al.. (2024). LLMArena: Assessing Capabilities of Large Language Models in Dynamic Multi-Agent Environments. 13055–13077. 3 indexed citations
8.
Cai, Hui, et al.. (2024). Association between different insulin resistance surrogates and osteoarthritis: a cross-sectional study from NHANES 1999–2018. BMC Musculoskeletal Disorders. 25(1). 901–901. 4 indexed citations
9.
Luo, Yuxin, Sha Fu, Wenjuan Yu, et al.. (2024). Effects of uric acid-lowering therapy (ULT) on renal outcomes in CKD patients with asymptomatic hyperuricemia: a systematic review and meta-analysis. BMC Nephrology. 25(1). 63–63. 7 indexed citations
10.
Chen, Junzhe, et al.. (2024). Therapeutic potential of microRNA-engineered exosomes in diabetic wound healing: a meta-analysis. Archives of Dermatological Research. 316(8). 493–493. 1 indexed citations
11.
Hu, Xuming, Xiaochuan Li, Junzhe Chen, et al.. (2024). Evaluating Robustness of Generative Search Engine on Adversarial Factoid Questions. 10650–10671.
12.
Zhou, Qin, Wenjuan Yu, Xiaofei Shao, et al.. (2023). #5705 EFFICACY AND SAFETY OF SACUBITRIL/VALSARTAN IN PATIENTS WITH STAGE 3B-5 CKD AND HYPERTENSION. Nephrology Dialysis Transplantation. 38(Supplement_1). 1 indexed citations
13.
Huang, Yuliang, et al.. (2023). #6496 CYCLIN D1 AMELIORATES ACUTE KIDNEY INJURY BY IMPROVING FATTY ACID OXIDATION VIA AMPK PATHWAY. Nephrology Dialysis Transplantation. 38(Supplement_1). 1 indexed citations
14.
Wu, Wenjing, Wenbiao Wang, Liying Liang, et al.. (2023). SARS-CoV-2 N protein induced acute kidney injury in diabetic db/db mice is associated with a Mincle-dependent M1 macrophage activation. Frontiers in Immunology. 14. 1264447–1264447. 10 indexed citations
15.
Wu, Chen, et al.. (2023). #5019 MORTALITY FOR COVID-19 IN UNDERGOING MAINTENANCE DIALYSIS PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS. Nephrology Dialysis Transplantation. 38(Supplement_1).
16.
Wang, Wenbiao, Junzhe Chen, Xueqing Yu, & Hui Y. Lan. (2022). Signaling mechanisms of SARS-CoV-2 Nucleocapsid protein in viral infection, cell death and inflammation. International Journal of Biological Sciences. 18(12). 4704–4713. 43 indexed citations
17.
Chen, Junzhe, Wenbiao Wang, Ying Tang, et al.. (2021). Inflammatory stress in SARS-COV-2 associated Acute Kidney Injury. International Journal of Biological Sciences. 17(6). 1497–1506. 24 indexed citations
18.
Tang, Ying, Qiuyan Huang, Sha Fu, et al.. (2021). Systematic review and subgroup analysis of the incidence of acute kidney injury (AKI) in patients with COVID-19. BMC Nephrology. 22(1). 52–52. 37 indexed citations
19.
Chen, Junzhe, Honghui Zeng, Mingsheng Zhu, et al.. (2020). The incidence, risk factors, and long-term outcomes of acute kidney injury in hospitalized diabetic ketoacidosis patients. BMC Nephrology. 21(1). 48–48. 38 indexed citations
20.
Tang, Ying, Junzhe Chen, Kai Huang, et al.. (2017). The incidence, risk factors and in-hospital mortality of acute kidney injury in patients after abdominal aortic aneurysm repair surgery. BMC Nephrology. 18(1). 184–184. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026